Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patient With Relapsed or Refractory Hairy Cell Leukemia (HCL)

NCT00462189 is registered in ClinicalTrials.gov with Cambridge Antibody Technology as lead sponsor.

NCT NCT00462189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patient With Relapsed or Refractory Hairy Cell Leukemia (HCL)
Lead sponsor
Cambridge Antibody Technology
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2007
Completion date
Not reported
Enrollment
40
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hairy cell leukemia, hcl, leukemia